Century Therapeutics Inc

IPSCNASDAQ · USD
1.86USD0.00 (-6.07%)
1510

Century Therapeutics Inc (IPSC) Historical Volatility

IPSC 30-day historical volatility is 58%. This ranks in the 28th percentile of readings over the past year.

Read more

Tracking IPSC historical volatility helps you see how much Century Therapeutics Inc's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, Century Therapeutics Inc's HV tells you what really happened. Use our scanner to monitor IPSC 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.

Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The IPSC 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing Century Therapeutics Inc's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.

Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma; CNTY-102, a CAR-iT targeting CD19 + CD79b for relapsed, refractory B-cell lymphoma and other B-cell malignancies; CNTY-104, a CAR-iT or CAR-iNK multi-specific candidate for acute myeloid leukemia; and CNTY-106, a CAR-iNK or CAR-iT multi-specific candidate for multiple myeloma.

Century Therapeutics, Inc. was founded in 2018 and is headquartered in Philadelphia, Pennsylvania.

Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts Century Therapeutics Inc's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where IPSC HV is running hot, cold, or in line. Make the IPSC 30 day historical volatility — and every other window — work for your edge instead of against it.

IV vs HV
Implied Volatility (IV) vs Historical Volatility (HV) over the past month.

As of September 16, 2026

IV - HV Difference
Difference between IV and HV over time. Positive values indicate IV > HV.

As of September 16, 2026

See how volatility has moved over time

Track IPSC historical volatility, spot where IV and realized volatility diverge, and find options that are priced in your favor right now.

Start your 14-day free trial